Proteinuria as a Risk Marker for the Progression of Chronic Kidney Disease in Patients on Predialysis Care and the Role of Angiotensin-Converting Enzyme Inhibitor/Angiotensin II Receptor Blocker Treatment

Publisher： Karger

E-ISSN： 1660-2110|121|1-2|c73-c82

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.121, Iss.1-2, 2012-10, pp. : c73-c82

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiotensin II receptor blocker prevents upper gastrointestinal bleeding in hypertensive patients with chronic kidney disease not on dialysis

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 7, 2015-07 ,pp. : 722-728

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reducing the Risk of Recurrences after Pulmonary Vein Isolation: What Is the Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers?

By  

Cardiology, Vol. 117, Iss. 1, 2010-09 ,pp. : 11-13

Karger

Access to resources Recommend Favorite

Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin‐Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 38, Iss. 1, 2018-01 ,pp. : 29-41

John Wiley & Sons Inc

Access to resources Recommend Favorite

Angiotensin‐converting enzyme inhibitors and bacterial pneumonia in patients with Parkinson disease

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 4, 2015-04 ,pp. : 593-596

John Wiley & Sons Inc

Access to resources Recommend Favorite

From Evidence to Rationale: Cardiovascular Protection by Angiotensin II Receptor Blockers Compared with Angiotensin-Converting Enzyme Inhibitors

By  

Cardiology, Vol. 117, Iss. 3, 2010-11 ,pp. : 163-173

Karger

Access to resources Recommend Favorite